Literature DB >> 118471

Present status of chemotherapy and chemoprophylaxis of human trypanosomiasis in the Western Hemisphere.

Z Brener.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 118471     DOI： 10.1016/0163-7258(79)90025-1

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN： 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  14 in total

1.  Activity of P536, a UDP-glucose analog, against Trypanosoma cruzi.

Authors:  A Alcina; M Fresno; B Alarcón
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

2.  Detection and characterization of antigens in urine of patients with acute, congenital, and chronic Chagas' disease.

Authors:  R S Corral; J Altcheh; S R Alexandre; S Grinstein; H Freilij; A M Katzin
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

3.  Experimental chemotherapy with combinations of ergosterol biosynthesis inhibitors in murine models of Chagas' disease.

Authors:  R A Maldonado; J Molina; G Payares; J A Urbina
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

4.  Novobiocin antagonism of amastigotes of Trypanosoma cruzi growing in cell-free medium.

Authors:  P G Pate; J S Wolfson; G L McHugh; S C Pan; M N Swartz
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

5.  2,3-diphenyl-1,4-naphthoquinone: a potential chemotherapeutic agent against Trypanosoma cruzi.

Authors:  Enrique I Ramos; Kristine M Garza; R L Krauth-Siegel; Julia Bader; Luiz E Martinez; Rosa A Maldonado
Journal:  J Parasitol       Date:  2009-04       Impact factor: 1.276

6.  Direct micromethod for diagnosis of acute and congenital Chagas' disease.

Authors:  H Feilij; L Muller; S M Gonzalez Cappa
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

7.  Arginine decarboxylase inhibitors reduce the capacity of Trypanosoma cruzi to infect and multiply in mammalian host cells.

Authors:  F Kierszenbaum; J J Wirth; P P McCann; A Sjoerdsma
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

8.  Molecular biology studies of tubercidin resistance in Trypanosoma cruzi.

Authors:  T Nozaki; J A Dvorak
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

9.  In vitro and in vivo activities of formycin B against Trypanosoma cruzi.

Authors:  R E McCabe; J S Remington; F G Araujo
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

10.  [Not Available].

Authors:  Shivali Gupta; Jian-Jun Wen; Nisha Jain Garg
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.